From: Spleen-preserving pancreatectomy with removal of splenic vessels: impact on splenic parenchyma ?
WDP group (n = 51) | KDP group (n = 36) | p value | |
---|---|---|---|
Age, y (median ± IQR) | 59 (± 17) | 51 (± 14) | 0.146 |
Centre, n (%) - Cliniques Saint-Luc - Hôpital Erasme | 27 (53%) 24 (47%) | 22 (58%) 16 (42%) | 0.618 |
Sex ratio (m/f) | 0.88 (24/27) | 0.57 (13/23) | 0.381 |
Body mass index, kg/m2 (median ± IQR) | 25.4 (± 5.0) | 26.5 (± 3.6) | 0.510 |
Charlson comorbidity index (median ± IQR) | 4 (± 3) | 2 (± 2) | 0.003 |
Indication for surgery, n (%) Malignant - Adenocarcinoma - Neuroendocrine tumour - Renal cancer metastasis - Other Benign - IPMN - Mucinous cystic tumour - Serous cystic tumour - Solid pseudopapillary tumour - Other | 30 (59%) 16 13 1 0 21 (41%) 6 4 1 4 6 | 14 (39%) 0 12 1 1 22 (61%) 6 5 3 2 6 | 0.023 |